Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program

by Alison Hirukawa, Harvey W. Smith, Dongmei Zuo, Catherine R. Dufour, Paul Savage, Nicholas Bertos, Radia M. Johnson, Tung Bui, Guillaume Bourque, Mark Basik, Vincent Giguère, Morag Park, William J. Muller
Published 2018-06-01

The Prognostic Ease and Difficulty of Invasive Breast Carcinoma

by Ali Tofigh, Matthew Suderman, Eric R. Paquet, Julie Livingstone, Nicholas Bertos, Sadiq M. Saleh, Hong Zhao, Margarita Souleimanova, Sean Cory, Robert Lesurf, Solmaz Shahalizadeh, Norberto Garcia Lopez, Yasser Riazalhosseini, Atilla Omeroglu, Josie Ursini-Siegel, Morag Park, Vanessa Dumeaux, Michael Hallett
Published 2014-10-01

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary

by Yibo Xue, Brian Meehan, Elizabeth Macdonald, Sriram Venneti, Xue Qing D. Wang, Leora Witkowski, Petar Jelinic, Tim Kong, Daniel Martinez, Geneviève Morin, Michelle Firlit, Atefeh Abedini, Radia M. Johnson, Regina Cencic, Jay Patibandla, Hongbo Chen, Andreas I. Papadakis, Aurelie Auguste, Iris de Rink, Ron M. Kerkhoven, Nicholas Bertos, Walter H. Gotlieb, Blaise A. Clarke, Alexandra Leary, Michael Witcher, Marie-Christine Guiot, Jerry Pelletier, Josée Dostie, Morag Park, Alexander R. Judkins, Ralf Hass, Douglas A. Levine, Janusz Rak, Barbara Vanderhyden, William D. Foulkes, Sidong Huang
Published 2019-02-01